[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2009, 35(2) 79-81 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
ϵͳ�Ժ���Ǵ�;B�ܰ�ϸ��;����
���������������
����ʢ
�����
PubMed
Article by
Article by

SLE B�ܰ�ϸ���������ƽ�չ

����ʢ �����

����ҽѧԺ����ҽԺ

ժҪ��

SLE�������Ƕ෽��ģ�B�ܰ�ϸ������������Ŀǰ�������ٴ�����δ�ձ�Ӧ�õ��·����� �����ٴ�����������֤ʵ����������Ч�ԡ���ȫ�Ժ�������, Ӧ��ǰ������, �Ӷ�Ϊ�����ṩ��������ѡ��, ������Ϊ��Щ�Դ�ͳ����������Ч���ѡ���Ч������Ӧ�����ߴ���ϣ������ȷ����Ч�ͳ��ڵIJ�����Ӧ�д�ͨ�����ģ�ٴ����鼰������ý�һ���õ���֤��

�ؼ����� ϵͳ�Ժ���Ǵ�;B�ܰ�ϸ��;����  

B-lymphocyte-targeted therapy for systemic lupus erythematosus

Abstract:

Treatment of SLE is versatile��B-lymphocyte-targeted therapy is a new clinical approach which has not been generally applied in China. International studies have proved it to be highly effective, safe and tolerable. So, it shows a fine application prospect and is expected to offer a new treatment approach to patients with SLE��especially to those resistant to conventional therapy and those suffering from serious adverse side effects. The true efficacy and long-term side effects of this approach remain to be further evaluated via large-scale trials and long-term follow-up��

Keywords:
�ո����� 2008-10-06 �޻����� 2008-10-16 ����淢������  
DOI:
������Ŀ:

ͨѶ����: ����ʢ
���߼��:

�ο����ף�
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־